HOME >> BIOLOGY >> NEWS
Cancer could be caught before it develops

An article published in the journal BMC Medical Informatics and Decision Making describes the creation of the first comprehensive listing and classification of precancers, drawn from the medical literature. Using this classification, the precancers have been organized into groups that share similar biologic profiles and, hopefully, similar treatments.

Precancers precede invasive cancers. They are localized changes in tissue lesions - identifiable by their morphologic structure. During carcinogenesis, when normal cells are transformed into cancerous cells, it is possible to identify precancers. Treating or removing precancerous cells at this early stage could prevent the prolonged, painful treatment and deaths of cancer sufferers. According to the authors of the article,

"Premalignant lesions are arguably the most important disease entities of modern man. In theory, the successful treatment of precancers would result in the eradication of most human cancers."

Despite their importance, until now there has been no attempt to produce a list of precancers, or to classify them according to their biological properties. Jules Berman of the National Cancer Institute at the NIH, and Donald Henson of George Washington University, Washington D.C., have produced a first draft of such a classification, which can be downloaded from http://65.222.228.150/jjb/presum.tar.gz. Berman and Henson worked from the National Library of Medicine's Unified Medical Language System (UMLS), extracting all of the terms relating to precancers from the 'Metathesaurus', and adding an additional 10% from their own knowledge. They identified 568 distinct precancer 'concepts', which have been described by over 4700 terms. Often one precancer is described in many different ways, and can have a number of terms that refer to it. The database includes terms from seven languages in addition to English terms.

Preca
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
20-Jun-2003


Page: 1 2

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Cancer gene MYC emerging as key research target
5. Cancer patient, heal thyself
6. USC researcher named General Motors Cancer Research Scholar
7. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
8. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
9. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
10. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
11. National Cancer Gene Therapy Foundation gives $4.0 million in research grants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2019)... ... March 22, 2019 , ... ... Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary kit chemistry that ... five-tube kit is comprised of preformatted master mixes for a simple, fast, and ...
(Date:3/18/2019)... FRANCISCO (PRWEB) , ... March 18, 2019 , ... ... patent portfolio in the microbiome industry and the third highest quality portfolio following ... by authors Manuel Fankhauser, Christian Moser, and Theodor Myfleler. uBiome executives Dr. ...
(Date:3/14/2019)... INDIANAPOLIS (PRWEB) , ... March 14, 2019 , ... ... and configurations on Mac, Windows and mobile, today announces the launch of its ... on sales volume, geographies and vertical markets, enabling them to add FileWave’s industry-leading ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... OKLAHOMA CITY (PRWEB) , ... March 14, 2019 ... ... AAALAC International for their facility in Oklahoma City, OK. EyeCRO joins the Department ... University of Oklahoma Health Sciences Center as the fifth institution in Oklahoma to ...
(Date:3/14/2019)... ... March 14, 2019 , ... ON NOVEMBER 27, 2018, Nova ... Eye Machine Canada Inc., had been given approval to begin a clinical patient ... Degeneration (AMD). , The previous month, the medical devices bureau of Health Canada ...
(Date:3/14/2019)... LAWRENCEVILLE, N.J. (PRWEB) , ... ... ... announced the launch of a preclinical gold standard solution for preclinical research ... Execution System (LES) with end-to-end workflows, connected systems and facilities, innovative technology-driven ...
(Date:3/11/2019)... ... March 11, 2019 , ... In this live webinar, the ... your clinical trial efficiency and experience. Participants will learn how to use the information ... to ensure that the simple or complex randomization scheme is properly designed and set ...
Breaking Biology Technology:
Cached News: